首页> 外文期刊>Journal of critical care >Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: A systematic review and meta-analysis of the literature
【24h】

Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: A systematic review and meta-analysis of the literature

机译:用败血症患者的羟乙基淀粉液体复苏与急性肾损伤的发病率增加以及肾置换疗法的使用:系统审查和荟萃分析文献

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Fluid resuscitation is a key intervention in sepsis, but the type of fluids used varies widely. The aim of this meta-analysis is to determine whether resuscitation with hydroxyethyl starches (HES) compared with crystalloids affects outcomes in patients with sepsis. Materials and Methods: Search of MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials up to February 2013. Studies that compared resuscitation with HES versus crystalloids in septic patients, and reported incidence of acute kidney injury (AKI), renal replacement therapy (RRT), transfusion of red blood cell (RBC) or fresh frozen plasma and/or mortality. Three investigators independently extracted data into uniform risk ratio measures. The Grading of Recommendations Assessment, Development and Evaluation framework was used to determine the quality of the evidence. Results: Ten trials (4624 patients) were included. An increased incidence of AKI (risk ratio [RR], 1.24 [95% Confidence Interval {CI}, 1.13-1.36], and need of RRT (RR, 1.36 [95% CI, 1.17-1.57]) was found in patients who received resuscitation with HES. Resuscitation with HES was also associated with increased transfusion of RBC (RR, 1.14 [95% CI, 1.01-1.93]), but not fresh frozen plasma (RR, 1.47 [95% CI, 0.97-2.24]). Furthermore, while intensive care unit mortality (RR, 0.74 [95% CI, 0.43-1.26]), and 28-day mortality (RR, 1.11 [95% CI, 0.96-1.28]) was not different, resuscitation with HES was associated with higher 90-day mortality (RR, 1.14 [95% CI, 1.04-1.26]). Conclusions: Fluid resuscitation practice with HES as in the meta-analyzed studies is associated with increased an increase in AKI incidence, need of RRT, RBC transfusion, and 90-day mortality in patients with sepsis. Therefore, we favor the use of crystalloids over HES for resuscitation in patients with sepsis.
机译:目的:流体复苏是败血症的关键干预,但使用的流体类型广泛变化。该荟萃分析的目的是确定与晶体氢甾体相比与羟乙基淀粉(HES)复苏影响败血症患者的结果。材料和方法:在2013年2月的控制试验中搜索Medline,Embase和Cochrane中央登记册。与脓毒症患者的复苏与HES的复苏复兴的研究,报道急性肾损伤(AKI),肾置换疗法的发病率(RRT ),输血红细胞(RBC)或新鲜冷冻血浆和/或死亡率。三个调查员独立提取数据均衡为均匀的风险比率。建议评估,发展和评估框架的评分用于确定证据的质量。结果:包括10项试验(4624名患者)。 AKI的发病率增加(风险比[RR],1.24 [95%置信区间{CI},1.13-1.36]和RRT的需要(RR,1.36 [95%CI,1.17-1.57])是在患者中发现的与HES收到复苏。与HER的复苏也与RBC的输血增加(RR,1.14 [95%CI,1.01-1.93])的复苏相关,但不是新鲜的冷冻等离子体(RR,1.47 [95%CI,0.97-24]) 。此外,同时重症监护单位死亡率(RR,0.74 [95%CI,0.43-1.26])和28天的死亡率(RR,1.11 [95%CI,0.96-1.28])没有不同,与他的复苏是与较高的90天死亡率相关(RR,1.14 [95%CI,1.04-1.26])。结论:与META分析的研究中一样与HES的流体复苏实践与AKI发病率的增加有关,需要RRT, RBC输血和败血症患者的90天死亡率。因此,我们赞成在败血症患者中使用晶体来复苏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号